Валюты / ACAD
ACAD: ACADIA Pharmaceuticals Inc
25.99
USD
0.24
(0.91%)
Курс ACAD за сегодня изменился на -0.91%. При этом минимальная цена на торгах достигала 25.82, а максимальная — 26.30.
Следите за динамикой ACADIA Pharmaceuticals Inc. Котировки в реальном времени помогут быстро реагировать на изменения рынка. Переключаясь между различными таймфреймами, можно отслеживать тенденции и динамику курса по минутам, часам, дням, неделям и месяцам. Используйте эту информацию для прогнозирования изменений на рынке и принятия взвешенных торговых решений.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
Новости ACAD
- Axsome Shares Up 20% in a Month: How Should You Play the Stock?
- Acadia Pharmaceuticals appoints Katcheves as chief business officer
- Acadia Pharmaceuticals stock hits 52-week high at $25.90
- JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
- Mizuho lowers Acadia Pharmaceuticals stock price target to $22 from $32
- Acadia Pharmaceuticals stock hits 52-week high at 25.24 USD
- Acadia Pharmaceuticals stock price target raised to $24 from $18 at Stifel
- Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
- Mizuho raises Acadia Pharmaceuticals stock price target on solid earnings
- Acadia Pharmaceuticals stock price target raised to $38 from $37 at Citizens JMP
- Acadia Pharmaceuticals Q2 2025 slides: revenue up 9%, raises full-year guidance
- Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
- Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
- Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards?
- Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
- Sarepta to Report Q2 Earnings: What's in Store for the Stock?
- GMAB vs. ACAD: Which Stock Is the Better Value Option?
- Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
- ACADIA Pharmaceutical: ACP-101 Read-Out Is Not Fully Priced In (NASDAQ:ACAD)
- Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
- Acadia stock price target raised to $32 from $22 at UBS on growth outlook
- Acadia Pharmaceuticals stock rating reiterated by H.C. Wainwright
- Acadia stock maintains outperform rating at RBC on pipeline potential
- Acadia Pharmaceuticals stock maintains outperform rating at BMO Capital
Дневной диапазон
25.82
26.30
Годовой диапазон
13.40
26.64
- Предыдущее закрытие
- 26.23
- Open
- 26.19
- Bid
- 25.99
- Ask
- 26.29
- Low
- 25.82
- High
- 26.30
- Объем
- 2.026 K
- Дневное изменение
- -0.91%
- Месячное изменение
- 9.66%
- 6-месячное изменение
- 32.00%
- Годовое изменение
- 57.04%
30 августа, суббота